Expert statistical consulting for the pharmaceutical industry, academia, NHS, and regulatory bodies. Drawing on over 15 years of hands-on trial methodology, AI research, and industry collaboration with Roche and AstraZeneca.
- Adaptive & Enrichment Trial Design
- Master Protocols & Platform Trials
- Biomarker Strategies & Regulatory Statistics
- Survival Analysis & Time-to-Event Methods
- AI for Drug Development & Patient Stratification
- Uncertainty Quantification & AI Assurance
- Multimodal & Precision Oncology Data Science
- Policy and strategy consulting on AI for health (UK-India AI Opportunities, invited by UK FCDO)
- Research programme leadership and portfolio review
- Expert advisory board and independent review panel roles
- Presentation to senior leaders and at invited forums and conferences
Grant Review & Expert Panels
Reviewer for the US National Science Foundation, NIHR Health Technology Assessment Programme, MRC Hubs for Trials Methodology Research, Cancer Research UK, Yorkshire Cancer Research, MRC AI for Biomedical & Health Research Panel, UKRI AI Innovation to Accelerate Health Research Panel, and the European Research Agency Personalised Medicine Review Panel.
To discuss a consulting engagement, advisory role, or collaboration, please get in touch. Initial consultations are available to discuss scope and fit.